Literature DB >> 9712603

Science, medicine, and the future: assessing thrombotic risk.

M Laffan1, E Tuddenham.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9712603      PMCID: PMC1113754          DOI: 10.1136/bmj.317.7157.520

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  10 in total

1.  A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.

Authors:  S R Poort; F R Rosendaal; P H Reitsma; R M Bertina
Journal:  Blood       Date:  1996-11-15       Impact factor: 22.113

Review 2.  Inherited thrombophilia: Part 1.

Authors:  D A Lane; P M Mannucci; K A Bauer; R M Bertina; N P Bochkov; V Boulyjenkov; M Chandy; B Dahlbäck; E K Ginter; J P Miletich; F R Rosendaal; U Seligsohn
Journal:  Thromb Haemost       Date:  1996-11       Impact factor: 5.249

Review 3.  Inherited thrombophilia: Part 2.

Authors:  D A Lane; P M Mannucci; K A Bauer; R M Bertina; N P Bochkov; V Boulyjenkov; M Chandy; B Dahlbäck; E K Ginter; J P Miletich; F R Rosendaal; U Seligsohn
Journal:  Thromb Haemost       Date:  1996-12       Impact factor: 5.249

4.  An in vitro analysis of the combination of hemophilia A and factor V(LEIDEN).

Authors:  C van 't Veer; N J Golden; M Kalafatis; P Simioni; R M Bertina; K G Mann
Journal:  Blood       Date:  1997-10-15       Impact factor: 22.113

5.  Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency.

Authors:  H H van Boven; P H Reitsma; F R Rosendaal; T A Bayston; V Chowdhury; K A Bauer; I Scharrer; J Conard; D A Lane
Journal:  Thromb Haemost       Date:  1996-03       Impact factor: 5.249

Review 6.  Factor V Leiden: should we screen oral contraceptive users and pregnant women?

Authors:  J P Vandenbroucke; F J van der Meer; F M Helmerhorst; F R Rosendaal
Journal:  BMJ       Date:  1996-11-02

7.  Mutation in blood coagulation factor V associated with resistance to activated protein C.

Authors:  R M Bertina; B P Koeleman; T Koster; F R Rosendaal; R J Dirven; H de Ronde; P A van der Velden; P H Reitsma
Journal:  Nature       Date:  1994-05-05       Impact factor: 49.962

8.  Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families.

Authors:  B P Koeleman; P H Reitsma; C F Allaart; R M Bertina
Journal:  Blood       Date:  1994-08-15       Impact factor: 22.113

9.  Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.

Authors:  B Dahlbäck; M Carlsson; P J Svensson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

Review 10.  Activation markers of coagulation.

Authors:  K A Bauer; R D Rosenberg
Journal:  Baillieres Clin Haematol       Date:  1994-09
  10 in total
  3 in total

1.  Factor XII deficiency and recurrent sixth nerve palsy.

Authors:  A Kipioti; O C Backhouse; P M Jacobs; M R Howard
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

2.  Cerebral sinus thrombosis and oral contraceptives. There are limits to predictability.

Authors:  J P Vandenbroucke
Journal:  BMJ       Date:  1998-08-22

3.  Review of thromboembolic prophylaxis in patients attending Cork University Hospital.

Authors:  Stephen Byrne; Daniel Timothy Weaver
Journal:  Int J Clin Pharm       Date:  2013-03-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.